Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Nov 18:9:173.
doi: 10.1186/s13023-014-0173-x.

A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases

Regina M Leadley  1 , Shona Lang  2 , Kate Misso  3 , Trudy Bekkering  4 , Janine Ross  5 , Takeyuki Akiyama  6 , Michael Fietz  7 , Roberto Giugliani  8 , Chris J Hendriksz  9 , Ngu Lock Hock  10 , Jim McGill  11 , Andrew Olaye  12 , Mohit Jain  13 , Jos Kleijnen  14   15
Affiliations
Multicenter Study

A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases

Regina M Leadley et al. Orphanet J Rare Dis. .

Abstract

Background: Morquio A (MPS IVA) is a rare disease characterised by a deficiency of N-acetylgalactosamine-6 sulfatase (GALNS) and presenting with short stature, abnormal gait, cervical spine instability and shortened lifespan.

Purpose: To prepare a systematic review of the prevalence of Morquio A in multiple countries and suggest recommendations for reporting rare diseases.

Methods: Medline, Medline In-Process, Medline Daily Update, Embase, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effects, Health Technology Assessment Database and PROSPERO were searched from inception to October 2013 to identify relevant information on the epidemiology of Morquio A. Forty Patient Organisation Representatives (POR) and Key Opinion Leaders (KOL) across 24 countries were contacted for data. Observational studies were included and case reports were excluded. Searches were performed without date or language restriction. Two researchers independently screened and extracted data. Quality of study reporting was assessed using a checklist adapted from STROBE (STrengthening the Reporting of OBservational studies in Epidemiology). Point or birth prevalence was stratified according to diagnostic method and discussed narratively.

Results: In total 9,074 records were retrieved from searching and 25 studies were included for data extraction. Twenty out of 40 KOL and POR responded (50%) and 9 provided data (23%). Point prevalence of Morquio A was 1 per 926,000 in Australia, 1 per 1,872,000 in Malaysia and 1 per 599,000 in UK and Morquio (unclassified) was 1 per 323, 000 in Denmark. Birth prevalence of Morquio A (using recommended diagnostic methods) ranged from 1 per 71,000 in UAE to 1 per 500,000 in Japan. All results were compromised by poor study reporting and internal validity.

Conclusions: The review highlighted that there is a misunderstanding of the definitions for prevalence and incidence in the field; that studies were poorly reported (diagnostic methods and patient characteristics) and that no suitable quality assessment tool exists. Overestimation and underestimation of prevalence data can occur. Bespoke reporting guidelines and a quality assessment tool specifically for prevalence of rare diseases are recommended.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of included studies.
Figure 2
Figure 2
Birth prevalence of Morquio A and Morquio unclassified.
See this image and copyright information in PMC

References

    1. Tomatsu S, Fukuda S, Masue M, Sukegawa K, Fukao T, Yamagishi A, Hori T, Iwata H, Ogawa T, Nakashima Y, Hanyu Y, Hashimoto T, Titani K, Oyama R, Suzuki M, Yagi K, Hayashi Y, Orii T. Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochem Biophys Res Commun. 1991;181(2):677–683. doi: 10.1016/0006-291X(91)91244-7. - DOI - PubMed
    1. Montano AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International morquio a registry: clinical manifestation and natural course of morquio a disease. J Inherit Metab Dis. 2007;30(2):165–174. doi: 10.1007/s10545-007-0529-7. - DOI - PubMed
    1. Lavery C, Hendriksz C: Mortality in patients with Morquio Syndrome A.JIMD Rep 2014, Epub 2014 Apr 10. - PMC - PubMed
    1. O'Brien JS, Gugler E, Giedion A, Wiessmann U, Herschkowitz N, Meier C, Leroy J. Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid beta-galactosidase deficiency. Clin Genet. 1976;9(5):495–504. doi: 10.1111/j.1399-0004.1976.tb01603.x. - DOI - PubMed
    1. Arbisser AI, Donnelly KA, Scott CI, Jr, DiFerrante N, Singh J, Stevenson RE, Aylesworth AS, Howell RR. Morquio-like syndrome with beta galactosidase deficiency and normal hexosamine sulfatase activity: mucopolysacchariodosis IVB. Am J Med Genet. 1977;1(2):195–205. doi: 10.1002/ajmg.1320010205. - DOI - PubMed

Publication types

LinkOut - more resources